ESC 365 - A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist increases blood pressure in stroke-prone spontaneous hypertensive rats

ESC2025 Premium Access

A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist increases blood pressure in stroke-prone spontaneous hypertensive rats

Session: Molecular actions of GLP-1 agonists and incretins

Topic: Hypertension, Pulmonary Hypertension

Speaker: Doctor Y. Ono (Fukuoka, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Yoshiyasu Ono

Kyushu University Faculty of Medical Sciences, Fukuoka (Japan)

0 follower

2 more presentations in this session

State-of-the-art lecture on molecular actions of GLP-1 agonists and incretins

Speaker: Professor E. Osto (Graz, AT)

Monocytes from CAD patients displayed M1 phenotype and released inflammatory mediators inducing endothelial dysfunction: M1 resolution and endothelial protection by SGLT2i + GLP-1Ra synergism

Speaker: Doctor A. Mroueh (Strasbourg, FR)

Access the full session

Molecular actions of GLP-1 agonists and incretins

Speakers: Doctor Y. Ono, Professor E. Osto, Doctor A. Mroueh

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources